Growth Hormone Secretagogue Signaling
growth_hormone_secretagogue_signaling
Growth Hormone Secretagogue Signaling
Understanding peptide and non-peptide compounds that stimulate endogenous GH secretion
Growth hormone secretagogue signaling describes pathways that increase endogenous GH release without direct GH injection.
This mechanism includes ghrelin-receptor agonists and related endocrine compounds that stimulate pulsatile GH output through upstream pituitary or receptor-based signaling.
The pathway is relevant to GH-axis support, sleep, body composition, and endocrine-aging discussions, but compounds within it vary substantially in evidence strength and clinical maturity.
The literature supports real GH stimulation across several compounds, but long-term body-composition or longevity claims often exceed the data.
This hub is most relevant to readers comparing endogenous GH stimulation strategies versus direct somatropin therapy.
mk-677|ipamorelin|hexarelin|sermorelin|cjc-1295-ipamorelin
ghrelin-receptor-agonists|growth-hormone-igf-axis
hormone-optimization|muscle-growth|body-recomposition
ghrelin-drive-stack|gh-optimization-stack|apex-stack
mk-677-vs-ipamorelin|mk-677-vs-sermorelin|ipamorelin-vs-sermorelin
study121|study124|study125|study039|study059|study060|study061|study108
Growth hormone secretagogue signaling explained
Scientific overview of peptides and compounds that stimulate endogenous growth hormone secretion.
/images/mechanisms/growth-hormone-secretagogue-signaling.jpg
published